James Mulshine to Sputum
This is a "connection" page, showing publications James Mulshine has written about Sputum.
Connection Strength
0.685
-
Sputum screening by quantitative microscopy: a new dawn for detection of lung cancer? Mayo Clin Proc. 1997 Aug; 72(8):788-90.
Score: 0.146
-
Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: assays for promotion factors in the bronchial lavage. J Cell Biochem Suppl. 1993; 17F:175-83.
Score: 0.106
-
Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol. 1988 Nov; 6(11):1685-93.
Score: 0.079
-
Lung cancer screening: panacea or pipe dream? Ann Oncol. 2005; 16 Suppl 2:ii215-9.
Score: 0.061
-
Considerations in developing successful, population-based molecular screening and prevention of lung cancer. Cancer. 2000 Dec 01; 89(11 Suppl):2465-7.
Score: 0.046
-
The early detection of occult lung cancer. Chest Surg Clin N Am. 2000 Nov; 10(4):737-49.
Score: 0.046
-
Prospects for lung-cancer screening. Lancet. 2000 Feb 19; 355(9204):592-3.
Score: 0.043
-
Molecular markers in early cancer detection. New screening tools. Chest. 1995 Jun; 107(6 Suppl):280S-286S.
Score: 0.031
-
The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group. Chest. 1994 Dec; 106(6 Suppl):385S-390S.
Score: 0.030
-
Early detection of lung cancer. Semin Oncol. 1993 Aug; 20(4):374-82.
Score: 0.028
-
Growth factors and other targets for rational application as intervention agents. Adv Exp Med Biol. 1992; 320:81-8.
Score: 0.025
-
Antibody 624H12, which detects lung cancer at early stages, recognizes a sugar sequence in the glycosphingolipid difucosylneolactonorhexaosylceramide (V3FucIII3FunLc6Cer). Arch Biochem Biophys. 1989 Nov 15; 275(1):309-14.
Score: 0.021
-
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Int J Oncol. 2002 Aug; 21(2):369-73.
Score: 0.013
-
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2237-46.
Score: 0.009